Stromedix (acq. by Biogen)

Investment Year: 2008
Exit: 2012
Sector: Healthcare
Geography: North America - East
Website: www.stromedix.com

Stromedix's initial focus is on chronic indications and plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec (NASDAQ: BIIB).

Team

Christopher Gabrieli

Stephen Kraus

News

Monday, February 27, 2012 (Source: Boston Globe)
Biogen Idec agrees to buy Stromedix

spotlight

Ethan Kurzweil Live in the TechStars Studio

BVP's Ethan Kurzweil, live in the TechStars studio, discuss SendGrid, Twilio and the new breed of API driven web infrastructure companies. The discussion is followed by a breakdown of the SendGrid pitch.

See the Video

Lifelock: Todd Davis

CEO Todd Davis talks about the Lifelock product and the keys to continued healthy growth

See the Video

Yelp: Jeremy Stoppelman

CEO Jeremy Stoppelman talks about what sets Yelp apart and his experience working with Bessemer

See the Video

Intucell: Rani Wellingstein

CEO Rani Wellingstein discusses Intucell's dynamic and automatic mobile network management platform, and the challenges of scaling a fast-growing company

See the Video

Mindbody: Rick Stollmeyer

CEO Rick Stollmeyer discusses the challenge of selling Saas software to the health and welfare industry

See the Video

Reputation.com: Michael Fertik

CEO Michael Fertik talks about Reputation.com's mission to give users control of their online reputations

See the Video

Twilio: Jeff Lawson

CEO Jeff Lawson talks about Twilio's simple web service API that allows developers to build live telephony applications in minutes

See the Video

Verastem: Christoph Westphal

CEO Christoph Westphal discusses how Verastem's focus on developing novel drugs targeting cancer stem cells could have a meaningful impact on cancer survival

See the Video

Bessemer Venture Partners